Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-062983

Chief Accounting Officer sold 541 shares at $0.75 ($405)

From the SEC's structured data for this filing

Trades in this filing

Hagen Brett R · Chief Accounting Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-05-17 Sale : show line 1 in the form −541 $0.75 $405 75,481 D
Open-market sales · 541 sh · avg $0.75 · $405
Loading xslF345X05/ownership.xml…